Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of Static Magnetic Fields on Neuroinflammation in Migraine

NCT: NCT07584382 · NOT_YET_RECRUITING

NCT IDNCT07584382
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2027-09-01

Brief Summary

We are conducting this research in individuals with migraines to find out if a daily magnet helmet application could alter migraine-related brain inflammation. Outcomes will be assessed through examining any changes in Translocator Protein (TSPO) binding on Positron Emission Tomography-Computed Tomography (PET-CT) imaging both before and after the magnet helmet intervention period. Additionally, patient-reported migraine symptoms will be measured using validated questionnaires administered during the four-week pre- and post- intervention monitoring periods.

Frequently Asked Questions

What is The Effect of Static Magnetic Fields on Neuroinflammation in Migraine?

The Effect of Static Magnetic Fields on Neuroinflammation in Migraine is a clinical trial registered under NCT07584382. Current status: NOT_YET_RECRUITING.

What is the status of NCT07584382?

The current status of NCT07584382 (The Effect of Static Magnetic Fields on Neuroinflammation in Migraine) is: NOT_YET_RECRUITING.

When did The Effect of Static Magnetic Fields on Neuroinflammation in Migraine start?

The Effect of Static Magnetic Fields on Neuroinflammation in Migraine started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.